Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
14.01. | JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US | ||
14.01. | JPM25: Regeneron CEO says it needs more 'arrows in its quiver' as Eylea HD sales fall short | ||
14.01. | JPM25, Day 2: GSK, Novartis, Sanofi and Lilly are set to present | ||
14.01. | JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales | ||
14.01. | Aragen snares $100M investment from Quadria Capital to expand its operations | ||
13.01. | Y-mAbs splits from commercial chief, tasks new hire with growing cancer drug sales | ||
13.01. | After Alkermes' makeover, CEO Richard Pops touts its pipeline program and rare biotech model | ||
10.01. | Lilly doubles down on its presence in India with new capability center, plans to hire 1,000+ | ||
10.01. | FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks | ||
10.01. | FDA cancels adcomm in 'positive' sign for Exelixis' Cabometyx bid in neuroendocrine tumors: analyst | ||
10.01. | Matt McNally rejoins Publicis, leaving Omnicom for CEO role at agency's health unit | ||
10.01. | Fierce Pharma Asia-A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets? | ||
10.01. | BD survey shows fear and discomfort delay gynecology visits | ||
09.01. | 10s for Tenpoint: Biotech preps for '26 market launch after phase 3 win for combo eye drop | ||
09.01. | Mendaera hires chief commercial officer for handheld medical robot launch | ||
09.01. | Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex | ||
09.01. | Catalyst settles with Teva, staving off Firdapse generic until 2035 | ||
09.01. | Havas starts GLP-1 video series to show value of episodic online content | ||
09.01. | With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in | ||
08.01. | Indian CDMO Anthem Biosciences files for $397M IPO amid expansion efforts | ||
08.01. | CDMO National Resilience plots 120 layoffs at former bluebird bio facility in Research Triangle Park | ||
08.01. | Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list | ||
08.01. | RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate | ||
08.01. | Swoop scoops up MyHealthTeam, buying patient social networks to boost pharma marketing | ||
08.01. | FleishmanHillard names BeiGene, HHS alum global managing director of health and life sciences |